The global small molecule innovator CDMO market was valued at USD 43.3 billion in 2025 and is expected to reach USD 69.4 billion by 2033, expanding at a 6.2% CAGR from 2026 to 2033. The market is projected to increase from USD 45.4 billion in 2026 to USD 69.4 billion by 2033. North America remained the leading regional market, accounting for 40.8% of global revenue in 2025, while Asia Pacific...